ELTROMBOPAG
eltrombopag 50 mg tablet, 28
ELTROMBOPAG (14112R)
14112R
Manner of administration:Oral
Restriction
Indication: Severe aplastic anaemia
Treatment phase: Continuing treatment - Second line treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 84 | # of repeats: 5 | DPMQ: $7,368.72 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Revolade | |||||